Cynthia M. Butitta
Director · Autolus Therapeutics plc
Individual
- 2025
- Jul 1, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Cynthia M. Butitta files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark Schoenberg - $4.48M in URGN purchases and sales in the last 12 months
- David C. Myles - $3.11M in OLMA purchases and sales in the last 12 months
- Shane William Charles Kovacs - $2.98M in OLMA purchases and sales in the last 12 months
- Shawnte Mitchell - $952K in OLMA purchases and sales in the last 12 months
- Cyrus Harmon - $662K in OLMA purchases and sales in the last 12 months
- Jason Drew Smith - $212K in URGN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Cynthia M. Butitta?
Cynthia M. Butitta is a corporate insider, tracked as Director of Autolus Therapeutics plc (AUTL). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Cynthia M. Butitta last file a Form 4?
The most recent primary Form 4 on record is dated 1 July 2026, one of 7 filings going back to 2025.
